Medpace Holdings, Inc. (MEDP) Tax Rate: 16.82%
Is Medpace Holdings, Inc.’s tax rate high or low?
Medpace Holdings, Inc.'s tax rate of 16.82% is 19% above its 5-year average of 14.08%, near the high end of its 5-year range (9.91%–16.82%).
5.62% above its 12-month average of 15.93%.
MEDP Tax Rate Chart
MEDP Average Tax Rate Chart
MEDP Current vs Average Tax Rate Chart
MEDP Tax Rate Metrics
TAX RATE
16.82%
TAX RATE AVG TTM
15.93%
TAX RATE AVG 3Y
15.21%
TAX RATE AVG 5Y
14.08%
TAX RATE AVG 10Y
16.87%
TAX RATE AVG 15Y
N/A
TAX RATE AVG 20Y
N/A
CURRENT VS TTM AVG
+5.62%
CURRENT VS 3Y AVG
+10.57%
CURRENT VS 5Y AVG
+19.43%
CURRENT VS 10Y AVG
-0.27%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Medpace Holdings, Inc. Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medpace Holdings, Inc. Tax Rate FAQ
- What is the tax rate for Medpace Holdings, Inc. (MEDP)?
- The tax rate for MEDP stock is 16.82%.
- Is Medpace Holdings, Inc.'s tax rate high or low?
- Medpace Holdings, Inc.'s tax rate of 16.82% is 19% above its 5-year average of 14.08%, near the high end of its 5-year range (9.91%–16.82%).
- What is the TTM average tax rate for Medpace Holdings, Inc. (MEDP)?
- The TTM average tax rate for MEDP stock is 15.93%.
- What is the 3Y average tax rate for Medpace Holdings, Inc. (MEDP)?
- The 3Y average tax rate for MEDP stock is 15.21%.
- What is the 5Y average tax rate for Medpace Holdings, Inc. (MEDP)?
- The 5Y average tax rate for MEDP stock is 14.08%.
- What is the 10Y average tax rate for Medpace Holdings, Inc. (MEDP)?
- The 10Y average tax rate for MEDP stock is 16.87%.
Medpace Holdings, Inc. Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2025-12-31 | 16.82% |
| 2024-12-31 | 15.03% |
| 2023-12-31 | 15.75% |
| 2022-12-31 | 13.25% |
| 2021-12-31 | 9.91% |
| 2020-12-31 | 13.74% |
| 2019-12-31 | 19.54% |
| 2018-12-31 | 22.10% |
| 2017-12-31 | 31.30% |
| 2016-12-31 | 38.86% |
| 2015-12-31 | -10.77% |
| 2014-12-31 | 26.76% |
| 2013-12-31 | 36.53% |
Related Metrics
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle